Shares of Fresenius Medical Care AG (NYSE:FMS) gapped up before the market opened on Thursday . The stock had previously closed at $44.31, but opened at $44.84. Fresenius Medical Care AG shares last traded at $45.55, with a volume of 186,376 shares.

Several research firms recently commented on FMS. Robert W. Baird reaffirmed a “hold” rating on shares of Fresenius Medical Care AG in a report on Monday, May 16th. Zacks Investment Research raised Fresenius Medical Care AG from a “sell” rating to a “hold” rating in a report on Wednesday, May 4th. DZ Bank AG reaffirmed a “sell” rating on shares of Fresenius Medical Care AG in a report on Tuesday, May 10th. Sanford C. Bernstein began coverage on Fresenius Medical Care AG in a report on Monday, April 11th. They set an “outperform” rating on the stock. Finally, Royal Bank Of Canada reaffirmed a “hold” rating on shares of Fresenius Medical Care AG in a report on Tuesday, May 24th. Two analysts have rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the stock. Fresenius Medical Care AG currently has an average rating of “Hold” and a consensus price target of $42.50.

The firm has a market cap of $27.88 billion and a P/E ratio of 26.56. The company’s 50 day moving average is $43.10 and its 200 day moving average is $42.95.

Fresenius Medical Care AG (NYSE:FMS) last released its quarterly earnings data on Tuesday, May 3rd. The company reported $0.75 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.42 by $0.33. The business had revenue of $4.21 billion for the quarter, compared to analyst estimates of $4.25 billion. The company’s revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.69 earnings per share. On average, equities research analysts anticipate that Fresenius Medical Care AG will post $2.03 EPS for the current year.

Several hedge funds have recently bought and sold shares of FMS. Comerica Bank increased its stake in Fresenius Medical Care AG by 5.4% in the fourth quarter. Comerica Bank now owns 35,387 shares of the company’s stock valued at $1,486,000 after buying an additional 1,798 shares during the last quarter. WBI Investments Inc. purchased a new stake in Fresenius Medical Care AG during the fourth quarter valued at $2,249,000. Bank of Montreal Can increased its stake in Fresenius Medical Care AG by 60.0% in the fourth quarter. Bank of Montreal Can now owns 56,700 shares of the company’s stock valued at $2,373,000 after buying an additional 21,264 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Fresenius Medical Care AG by 3.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 107,376 shares of the company’s stock valued at $4,493,000 after buying an additional 3,694 shares during the last quarter. Finally, US Bancorp DE increased its stake in Fresenius Medical Care AG by 4.0% in the fourth quarter. US Bancorp DE now owns 274,935 shares of the company’s stock valued at $11,503,000 after buying an additional 10,479 shares during the last quarter.

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.